I'll play devil's advocate for a minute:
1. How do you know your vacuum system is reliable and provides continuous suction (meets its purpose, appropriate performance)?
2. The device has clinical application. Why wouldn't it have a clinical evaluation of its safety?
There's probably good answers to all of these, and these good answers need to be compiled into a documented justification.
I AM NOT AN EXPERT IN THE FOLLOWING. Anyone who understands better, feel free to correct me. I have some EU MDR training and experience, but this particular niche I'm just dipping my toes into.
From what I understand, you always need a clinical evaluation, attached to your Technical File documentation. Clinical evaluation doesn't just mean using a device on a bunch of people and seeing if it works and doesn't cause side effects (a clinical
investigation) - it also involves explaining why your product will be able to do its job safely and effectively compared with similar devices on the market. Your company may piggy-back off of other's research for similar devices, but I'm not seeing anything that says you can skip the evaluation. You may want to check your technical file to see if you have such a justification.
3. A clinical evaluation shall follow a defined and methodologically sound procedure based on the following:
(a)
a critical evaluation of the relevant scientific literature currently available relating to the safety, performance, design characteristics and intended purpose of the device, where the following conditions are satisfied:
—
it is demonstrated that the device subject to clinical evaluation for the intended purpose is equivalent to the device to which the data relate, in accordance with Section 3 of Annex XIV, and
—
the data adequately demonstrate compliance with the relevant general safety and performance requirements;
(b)
a critical evaluation of the results of all available clinical investigations, taking duly into consideration whether the investigations were performed under Articles 62 to 80, any acts adopted pursuant to Article 81, and Annex XV; and
(c)
a consideration of currently available alternative treatment options for that purpose, if any.
Taken from here:
https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=uriserv:OJ.L_.2017.117.01.0001.01.ENG